ArticleScientific reports2021

PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma.

Daiju Yokoyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.